Branson invests in ethical stem cell storage. Times doesn't understand the difference

Interesting news in the Times: Stem-cell storage firm takes Branson into biotech sector. Richard Branson is investing in stem cell storage from the placenta or the umbilical cord after birth. This is good news if he is going to keep out of embryonic stem cells.

Sadly, David Robertson, the author of the article, obviously finds the whole ethical thing a bit challenging. He says,
Some anti-abortion groups believe that any use of stem cells will lead to human cloning.
Listen my dear chap. EMBRYOS - baby human beings - killing them: that's what we don't like. Taking blood from the umbilical cord really is a different thing. Think about it.

Popular posts from this blog

Plenary indulgences not impossible

Confraternity of Catholic Clergy Colloquium 2017

Hippolytus and Eucharistic Prayer II

CD 297: Laity and the Divine Office

Event: Day for Catholic Home Educators